secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001842952-23-000074
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics updates corporate presentation for investor meetings
-------------------------------------------------------------------------

- On August 7, 2023, Context Therapeutics updated its corporate presentation for use in investor meetings.
- The presentation was filed as Exhibit 99.1 to Form 8-K.
- The company's CEO Martin A. Lehr signed the filing.
- The presentation includes information about advancing medicines for solid tumors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295223000074/0001842952-23-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295223000074/cntx-20230807.htm
  HTML page:      https://secwatch.observer/filing/0001842952-23-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer